Kazia Therapeutics Limited American Depositary Shares KZIA

$13.58 -19.64% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-08-28 View →
424B5 PROSPECTUS SUPPLEMENT 2026-08-28 View →
424B5 PROSPECTUS SUPPLEMENT 2026-08-27 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-08-27 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-07-28 View →
4 Insider transaction 2026-07-08 View →
4 Insider transaction 2026-07-08 View →
4 Insider transaction 2026-07-08 View →
4 Insider transaction 2026-07-08 View →
4 Insider transaction 2026-07-08 View →
4 Insider transaction 2026-07-08 View →
4 Insider transaction 2026-06-23 View →
4 Insider transaction 2026-06-23 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-06-02 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-05-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-04-27 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-04-15 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-04-13 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-31 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-30 View →
6-K 6-K 2026-03-19 View →
6-K 6-K 2026-01-27 View →
6-K 6-K 2025-12-19 View →
6-K 6-K 2025-12-10 View →
6-K 6-K 2025-12-05 View →
6-K 6-K 2025-12-02 View →
6-K 6-K 2025-11-18 View →
20-F 20-F 2025-11-07 View →
6-K 6-K 2025-10-07 View →
6-K FORM 6-K 2025-10-02 View →
6-K 6-K 2025-09-11 View →
6-K 6-K 2025-08-01 View →
6-K 6-K 2025-07-25 View →
424B5 424B5 2025-07-25 View →
6-K 6-K 2025-07-09 View →
6-K FORM 6-K 2025-06-11 View →
6-K 6-K 2025-06-10 View →
6-K FORM 6-K 2025-06-05 View →
6-K FORM 6-K 2025-05-28 View →
6-K FORM 6-K 2025-05-15 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$13.58
Market Cap
$155.18 million
52-Week Range
$4.86 $17.40
Average Volume
247K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.